nocodazole has been researched along with Ewing Sarcoma in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment of nocodazole-synchronized cells with JNJ-7706621 was able to override mitotic arrest by preventing spindle checkpoint signaling, resulting in failure of chromosome alignment and segregation." | 1.38 | Growth suppression and mitotic defect induced by JNJ-7706621, an inhibitor of cyclin-dependent kinases and aurora kinases. ( Hara, A; Kawai, G; Kimura, M; Matsuhashi, A; Nagano, A; Ohno, T; Okano, Y; Saio, M; Saitou, M; Shimizu, K; Takigami, I; Yamada, K, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsuhashi, A | 1 |
| Ohno, T | 1 |
| Kimura, M | 1 |
| Hara, A | 1 |
| Saio, M | 1 |
| Nagano, A | 1 |
| Kawai, G | 1 |
| Saitou, M | 1 |
| Takigami, I | 1 |
| Yamada, K | 1 |
| Okano, Y | 1 |
| Shimizu, K | 1 |
1 other study available for nocodazole and Ewing Sarcoma
| Article | Year |
|---|---|
Growth suppression and mitotic defect induced by JNJ-7706621, an inhibitor of cyclin-dependent kinases and aurora kinases.
Topics: Animals; Antineoplastic Agents; Aurora Kinase A; Aurora Kinase B; Aurora Kinases; Bone Neoplasms; Ce | 2012 |